About us
TetraKit Technologies (“TetraKit”) was founded in 2021 as a spin-out from the University of Copenhagen. The key innovations in our company originate from the Herth lab at the University of Copenhagen’s Institute of Chemistry, a global leader in utilizing tetrazine ligation click chemistry in radiopharmaceutical applications. Our mission at TetraKit is to develop and market our innovative radiolabeling platform for the synthesis of radiopharmaceutical drugs and diagnostic agents, particularly those incorporating radiohalogens, which are among the most effective radionuclides for a new generation of radiopharmaceuticals
Business Model
At TetraKit Technologies, we develop innovative radiopharmaceuticals in-house and collaborate with partners to broaden their application across oncology.
